Rhoen Klinikum AG (WBO:RHK) Beta: -0.3235 (As of Jun. 28, 2026)


WBO:RHK Rhoen Klinikum AG WBO:RHK
74 GF Score
Price €12.80
GF Value €13.59
! 3 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG Beta?

Rhoen Klinikum AG WBO:RHK +0.79% 74 Beta is -0.3235 as of Jun. 28, 2026. GuruFocus rates WBO:RHK with a GF Score™ of 74/100 and a GF Value™ of €13.59. The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-28), Rhoen Klinikum AG's Beta is -0.3235.


Rhoen Klinikum AG  (WBO:RHK) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Rhoen Klinikum AG Beta Related Terms


Rhoen Klinikum AG Beta Historical Data

* Premium members only.

The historical data trend for Rhoen Klinikum AG's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhoen Klinikum AG Beta Chart

Rhoen Klinikum AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 0.04 0.06 0.05 0.00

Rhoen Klinikum AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.17 -0.26 0.00 -0.22

WBO:RHK vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhoen Klinikum AG Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Beta distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's Beta falls into.


WBO:RHK
74GF Score
Rhoen Klinikum AG WBO:RHK
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhoen Klinikum AG Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.3235 mean?
Rhoen Klinikum AG (WBO:RHK) has a Beta of -0.3235 as of Jun. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Rhoen Klinikum AG and its competitors.
Is Rhoen Klinikum AG's Beta too high?
Rhoen Klinikum AG's current Beta is -0.3235. Overall, Rhoen Klinikum AG has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Beta compare to HCA and THC?
Rhoen Klinikum AG's Beta of -0.3235 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Rhoen Klinikum AG and its competitors. Rhoen Klinikum AG's current Beta is -0.3235. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current Beta of -0.3235. The stock's GF Value™ is €13.59, compared to a current price of €12.80 — trading 5.8% below its estimated fair value. The current Beta is -0.3235. Rhoen Klinikum AG's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current Beta is -0.3235 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued. The current stock price of €12.80 is trading 5.8% below its estimated GF Value™ of €13.59.

Key valuation signals for WBO:RHK:

  • Beta: -0.3235
  • GF Value™: €13.59 vs. price of €12.80 (5.8% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rhoen Klinikum AG Business Description

Other Exchanges 0NQH:UKRHK:Germany
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
74GF Score

Get the complete analysis for WBO:RHK

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.80
Price
€13.59
GF Value